SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-018883
Filing Date
2023-05-24
Accepted
2023-05-24 14:05:23
Documents
30
Period of Report
2023-05-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39868
2 ex99-1.htm EX-99.1 14684
3 ex99-1_001.jpg GRAPHIC 349404
4 ex99-1_002.jpg GRAPHIC 588877
5 ex99-1_003.jpg GRAPHIC 296583
6 ex99-1_004.jpg GRAPHIC 319575
7 ex99-1_005.jpg GRAPHIC 205999
8 ex99-1_006.jpg GRAPHIC 380847
9 ex99-1_007.jpg GRAPHIC 271495
10 ex99-1_008.jpg GRAPHIC 314054
11 ex99-1_009.jpg GRAPHIC 292789
12 ex99-1_010.jpg GRAPHIC 363203
13 ex99-1_011.jpg GRAPHIC 379095
14 ex99-1_012.jpg GRAPHIC 496982
15 ex99-1_013.jpg GRAPHIC 362171
16 ex99-1_014.jpg GRAPHIC 382417
17 ex99-1_015.jpg GRAPHIC 448184
18 ex99-1_016.jpg GRAPHIC 323503
19 ex99-1_017.jpg GRAPHIC 590030
  Complete submission text file 0001493152-23-018883.txt   8998100

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE pcsa-20230524.xsd EX-101.SCH 3004
21 XBRL LABEL FILE pcsa-20230524_lab.xml EX-101.LAB 34240
22 XBRL PRESENTATION FILE pcsa-20230524_pre.xml EX-101.PRE 22389
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3611
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 23953341
SIC: 2834 Pharmaceutical Preparations